PGs drug
Evidence from:
primary |
all sources
Related entities (4)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| PGs | interacts_with | African American | — | 1 |
| PGs | associated_with | ancestry principal components | — | 1 |
| PGs | interacts_with | European ancestry | — | 1 |
| PGs | associated_with | study cohort | — | 1 |
Mentioned in (10)
Papers in which this entity is mentioned.
- Consortium profile: the methylation, imaging and NeuroDevelopment (MIND) consortium. (2026)
- Trajectories of genetic risk across dimensions of alcohol use behaviors. (2025)
- Alcohol Use Disorder Polygenic Score Compared With Family History and ADH1B. (2024)
- Clinical, genomic, and neurophysiological correlates of lifetime suicide attempts among individuals with alcohol dependence. (2024)
- The Polygenic Score Catalog: new functionality and tools to enable FAIR research. (2024)
- Recent advances in polygenic scores: translation, equitability, methods and FAIR tools. (2024)
- Consortium Profile: The Methylation, Imaging and NeuroDevelopment (MIND) Consortium. (2024)
- Biobank-scale methods and projections for sparse polygenic prediction from machine learning. (2023)
- Polygenic scoring accuracy varies across the genetic ancestry continuum. (2023)
- Research Review: A guide to computing and implementing polygenic scores in developmental research. (2022)
Merged raw entities (5)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| pgs | drug | 13 | 43 |
| pgs | phenotype | 9 | 16 |
| proteoglycans | drug | 4 | 5 |
| pgs | cohort | 3 | 3 |
| pgss | drug | 2 | 2 |